NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 13, 2025 — Strawberry Fields REIT expands in $98B elderly care market with 142 facilities across 10 states. Learn about STRW's growth strategy in skilled nursing and healthcare real estate.
November 13, 2025 — NanoViricides closes $6M direct offering to fund antiviral drug development. Clinical stage company advancing broad-spectrum NV-387 and shingles treatment NV-HHV-1.
November 13, 2025 — HeartBeam partners with HeartNexus to provide 24/7 remote ECG monitoring with cardiologist interpretation. Revolutionary portable device enables cardiac assessment anywhere, addressing global cardiovascular disease challenges.
November 13, 2025 — Lantern Pharma reports 48% clinical benefit in AI-driven cancer trial, advances multiple oncology programs with Phase 1b/2 studies planned for TNBC, NSCLC, and bladder cancer.
November 13, 2025 — SOBRsafe reports 136% Q3 revenue growth driven by SOBRsure GEN 2 alcohol detection device sales. Company sold 277 devices, increased software revenue 60.5% to $152.2K.
November 13, 2025 — Texas A&M scientists use astatine-211, the rarest natural element, to kill cancer cells while sparing healthy tissue. This breakthrough radiotherapy could revolutionize cancer treatment approaches worldwide.
November 13, 2025 — Davies Hothem Injury Law secures $1.2M verdict for crash victim after defense offered only $25K. Learn how experienced trial counsel achieved justice in complex car accident case.
November 13, 2025 — Illinois chiropractor secretly filmed nude patients during treatments. Dixon Law Office represents victims in major privacy violation case. Learn about legal options and accountability.
November 13, 2025 — BRYGE AI wins Silver Stevie Award for innovative ADHD communication assistant that helps neurotypicals communicate more effectively with ADHD individuals using AI technology.
November 12, 2025 — Albrechtsen & Fanelli Orthodontics offers advanced orthodontic care in South Ogden with personalized treatments including Invisalign and traditional braces using cutting-edge technology.
November 12, 2025 — HeartBeam ranked 2nd globally in portable ECG innovation by PatentVest. The medical tech company's synthesis-ECG system transforms cardiac care with FDA-cleared portable monitoring technology for home use.
November 12, 2025 — Oragenics regains NYSE compliance, advances ONP-002 Phase IIa trial for concussion treatment, and partners with Receptor.AI using AI to develop neurological therapeutics for Parkinson's and Alzheimer's.
November 12, 2025 — Annovis Bio reports Q3 2025 progress with full Phase 3 Alzheimer's trial activation and promising biomarker data showing reduced inflammation and neurodegeneration for buntanetap therapy.
November 12, 2025 — Babston Oral Surgery in Mobile, AL offers advanced dental implants for permanent tooth replacement. Learn about personalized care, state-of-the-art technology, and life-changing benefits.
November 12, 2025 — Wellness Eternal releases October 2025 Biohacking Index Report featuring top 10 verified wellness brands. Discover data-backed longevity solutions and evidence-based health innovations.
November 12, 2025 — CollectionPro acquires Chicago hospital client, expanding healthcare reimbursement recovery services. Company specializes in No Surprises Act compliance and out-of-network billing disputes with no recovery, no fee model.
November 12, 2025 — Co-Diagnostics forms CoMira Diagnostics joint venture in Saudi Arabia to localize PCR technology across Middle East. Utah company recognized for global healthcare expansion.
November 11, 2025 — March Biosciences receives FDA RMAT designation for MB-105 CAR-T therapy targeting T-cell lymphoma. Accelerated development pathway for novel cancer treatment addressing unmet medical need.
November 11, 2025 — NanoViricides secures $6M in funding to advance broad-spectrum antiviral drug development. Clinical-stage company progressing NV-387 toward Phase II trials for multiple viral infections.
November 11, 2025 — Oncotelic Therapeutics and Sapu Bioscience publish groundbreaking nanoparticle research in International Journal of Molecular Sciences, revealing new drug delivery potential for cancer and rare diseases.